iTrade4Profit

Accurate short term trading calls

Our Calls
	Latest
	This Month
	This year
	Last Year


Search Calls

Contact Us

Related Links

	Share Market Tips
	Indian Share Tips
	Free Market Tips
	Day Trading Tips
	Intraday Tips

16 out of 17 calls for AARTIPHARM proved profitable, with an average profit of 3% within 3 trading days.

The following are the details of the last 30 calls given by us for Aarti Pharmalabs Limited (AARTIPHARM).

Please note that few or all of these calls may not appear in the daily pre-market calls published on the website. Pre-market calls are published on the website only if the scrip closes above Rs. 100/-. However, all pre-market calls are available to our registered subscribers in their mail box. To register, please use the Contact Us link.

1) On 28 Mar, 2024, we gave a SELL call for AARTIPHARM. The scrip opened at 437.15 and reached a low of 432.05 within next 3 trading days, giving an opportunity to book of profit of Rs.5.1 i.e. 1.17%.

2) On 11 Mar, 2024, we gave a SELL call for AARTIPHARM. The scrip opened at 456.1 and reached a low of 410.05 within next 3 trading days, giving an opportunity to book of profit of Rs.46.05 i.e. 10.1%.

3) On 7 Mar, 2024, we gave a SELL call for AARTIPHARM. The scrip opened at 456 and reached a low of 441.05 within next 3 trading days, giving an opportunity to book of profit of Rs.14.95 i.e. 3.28%.

4) On 1 Mar, 2024, we gave a SELL call for AARTIPHARM. The scrip opened at 491.8 and reached a low of 459.1 within next 3 trading days, giving an opportunity to book of profit of Rs.32.7 i.e. 6.65%.

5) We gave a BUY call for AARTIPHARM on 19 Feb, 2024. The scrip opened at 545 but did not rise as expected. However, it fell to 526 before closing at 529.25. Although we consider this as a rare Failed Call

6) We gave a BUY call for AARTIPHARM on 12 Jan, 2024. The scrip opened at 557.2 and rose to 560 within next 3 trading days, giving an opportunity to book of profit of Rs.2.8 i.e. 0.5%.

7) On 4 Jan, 2024, we gave a SELL call for AARTIPHARM. The scrip opened at 499.35 and reached a low of 485.55 within next 3 trading days, giving an opportunity to book of profit of Rs.13.8 i.e. 2.76%.

8) We gave a BUY call for AARTIPHARM on 5 Dec, 2023. The scrip opened at 465.7 and rose to 497 within next 3 trading days, giving an opportunity to book of profit of Rs.31.3 i.e. 6.72%.

9) We gave a BUY call for AARTIPHARM on 4 Dec, 2023. The scrip opened at 448 and rose to 484.9 within next 3 trading days, giving an opportunity to book of profit of Rs.36.9 i.e. 8.24%.

10) We gave a BUY call for AARTIPHARM on 20 Nov, 2023. The scrip opened at 405.95 and rose to 412.95 within next 3 trading days, giving an opportunity to book of profit of Rs.7 i.e. 1.72%.

11) We gave a BUY call for AARTIPHARM on 6 Sep, 2023. The scrip opened at 436.9 and rose to 457 within next 3 trading days, giving an opportunity to book of profit of Rs.20.1 i.e. 4.6%.

12) We gave a BUY call for AARTIPHARM on 21 Aug, 2023. The scrip opened at 362.1 and rose to 393 within next 3 trading days, giving an opportunity to book of profit of Rs.30.9 i.e. 8.53%.

13) On 12 Jul, 2023, we gave a SELL call for AARTIPHARM. The scrip opened at 340 and reached a low of 327.5 within next 3 trading days, giving an opportunity to book of profit of Rs.12.5 i.e. 3.68%.

14) We gave a BUY call for AARTIPHARM on 7 Jun, 2023. The scrip opened at 396.05 and rose to 404.25 within next 3 trading days, giving an opportunity to book of profit of Rs.8.2 i.e. 2.07%.

15) On 5 Apr, 2023, we gave a SELL call for AARTIPHARM. The scrip opened at 275.15 and reached a low of 275.1 within next 3 trading days, giving an opportunity to book of profit of Rs.0.05 i.e. 0.02%.

16) We gave a BUY call for AARTIPHARM on 23 Mar, 2023. The scrip opened at 285.25 and rose to 299.35 within next 3 trading days, giving an opportunity to book of profit of Rs.14.1 i.e. 4.94%.

17) We gave a BUY call for AARTIPHARM on 8 Mar, 2023. The scrip opened at 303 and rose to 307.9 within next 3 trading days, giving an opportunity to book of profit of Rs.4.9 i.e. 1.62%.

comments powered by Disqus